Ilka Herrgott
University of Münster(DE)
Publications by Year
Research Areas
Systemic Sclerosis and Related Diseases, Lipid Membrane Structure and Behavior, Dermatologic Treatments and Research, Sphingolipid Metabolism and Signaling, Mast cells and histamine
Most-Cited Works
- → Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group(2014)423 cited
- → High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P 3 Lysophospholipid Receptor(2006)412 cited
- → Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy(2010)290 cited
- → Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors(2009)127 cited
- → Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis(2014)101 cited
- → Neutrophilic Epitheliotropism Is a Histopathological Clue to Neutrophilic Urticarial Dermatosis(2015)80 cited
- → Kapillarmikroskopie(2010)45 cited
- → Intravenous Sphingosylphosphorylcholine Protects Ischemic and Postischemic Myocardial Tissue in a Mouse Model of Myocardial Ischemia/Reperfusion Injury(2010)21 cited
- → Management of cutaneous vascular complications in systemic scleroderma: experience from the German network(2008)13 cited
- → The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase‐1 antibodies(2015)13 cited